Literature DB >> 7836078

Radical radiotherapy for early nonsmall cell lung cancer.

P H Graham1, V J Gebski, A O Langlands.   

Abstract

PURPOSE: To evaluate the results of a departmental treatment policy in a consecutive series of patients with nonsmall cell carcinoma of the lung. A second purpose was to estimate the survival of patients treated with radical intent. A third purpose was to estimate the impact of comorbidity on the selection of patients for treatment and on its outcome. METHODS AND MATERIALS: The records of 720 consecutive patients referred to a single Department of Radiation Oncology between 1979 and 1985 were reviewed. One hundred fifty patients with early stage (Stage I and II disease) were studied in detail and the results are presented for the outcome of 103 patients treated by radical radiotherapy. All patients were followed for a minimum period of five years or until death.
RESULTS: Patients referred for radiation therapy were elderly and usually had squamous cell carcinoma of the lung. Comorbidity was significant as was weight loss which occurred in a third of patients. The overall survival of patients treated with radical intent was 13%. In a small subgroup of patients with T1 tumors without weight loss and aged under 70 survival reached 50% at 5 years with no treatment-related mortality and with insignificant treatment-related morbidity.
CONCLUSION: Highly selected subsets of patients suitable for treatment with radiotherapy can be defined equally as well as highly selected subsets of patients can be selected for surgery. Treatment outcome can be surprisingly good in these subsets indicating that the treatment of nonsmall cell lung cancer, particularly in older patients without comorbidity should not automatically be by a surgical approach.

Entities:  

Mesh:

Year:  1995        PMID: 7836078     DOI: 10.1016/0360-3016(94)E0137-9

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  11 in total

1.  A method for improved verification of entire IMRT plans by film dosimetry.

Authors:  Vesna Jacob; Peter Kneschaurek
Journal:  Strahlenther Onkol       Date:  2009-02-18       Impact factor: 3.621

Review 2.  Radical radiotherapy for stage I/II non-small cell lung cancer in patients not sufficiently fit for or declining surgery (medically inoperable): a systematic review.

Authors:  N P Rowell; C J Williams
Journal:  Thorax       Date:  2001-08       Impact factor: 9.139

3.  Influenza infection induces host DNA damage and dynamic DNA damage responses during tissue regeneration.

Authors:  Na Li; Marcus Parrish; Tze Khee Chan; Lu Yin; Prashant Rai; Yamada Yoshiyuki; Nona Abolhassani; Kong Bing Tan; Orsolya Kiraly; Vincent T K Chow; Bevin P Engelward
Journal:  Cell Mol Life Sci       Date:  2015-03-26       Impact factor: 9.261

Review 4.  Inoperable localized stage I and stage II non-small-cell lung cancer.

Authors:  Eric L Gressen; Walter J Curran
Journal:  Curr Treat Options Oncol       Date:  2002-02

Review 5.  Management of patients with non-small cell lung cancer and poor performance status.

Authors:  Ramaswamy Govindan
Journal:  Curr Treat Options Oncol       Date:  2003-02

6.  Treatment of T3N0 non-small cell lung cancer with chest wall invasion using stereotactic body radiotherapy.

Authors:  William R Kennedy; Prashant Gabani; John Nikitas; Pamela P Samson; Clifford G Robinson; Jeffrey D Bradley; Michael C Roach
Journal:  Clin Transl Radiat Oncol       Date:  2019-02-21

7.  Five- Versus Ten-Fraction Regimens of Stereotactic Body Radiation Therapy for Primary and Metastatic NSCLC.

Authors:  Cole R Steber; Ryan T Hughes; Michael H Soike; Travis Jacobson; Corbin A Helis; Joshua C Farris; Michael K Farris
Journal:  Clin Lung Cancer       Date:  2020-09-18       Impact factor: 4.785

Review 8.  Early stage medically inoperable non-small cell lung cancer.

Authors:  Jeffrey A Bogart; Ernest Scalzetti; Elisabeth Dexter
Journal:  Curr Treat Options Oncol       Date:  2003-02

9.  Endovascular coils as lung tumour markers in real-time tumour tracking stereotactic radiotherapy: preliminary results.

Authors:  Jean-Briac G Prévost; Joost J Nuyttens; Mischa S Hoogeman; Johan J Pöll; Lukas C van Dijk; Peter M T Pattynama
Journal:  Eur Radiol       Date:  2008-04-04       Impact factor: 5.315

10.  Implantation of computed tomography-guided Iodine-125 seeds in combination with chemotherapy for the treatment of stage III non-small cell lung cancer.

Authors:  Xiaodong Huo; Bin Huo; Huixing Wang; Lei Wang; Qiang Cao; Guangjun Zheng; Junjie Wang; Shude Chai; Zuncheng Zhang; Kuo Yang; Yuanjie Niu; Haitao Wang
Journal:  J Contemp Brachytherapy       Date:  2017-12-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.